These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 21673129

  • 1. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.
    Kadam RS, Jadhav G, Ogidigben M, Kompella UB.
    Drug Metab Dispos; 2011 Sep; 39(9):1529-37. PubMed ID: 21673129
    [Abstract] [Full Text] [Related]

  • 2. Ocular and systemic pharmacokinetics of brimonidine and brinzolamide after topical administration in rabbits: comparison between fixed-combination and single-drug formulations.
    Suzuki G, Kunikane E, Shigemi W, Shinno K, Kozai S, Kurata M, Kawamura A.
    Curr Eye Res; 2021 Mar; 46(3):380-386. PubMed ID: 32706598
    [Abstract] [Full Text] [Related]

  • 3. Preclinical overview of brinzolamide.
    DeSantis L.
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S119-29. PubMed ID: 10665514
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors.
    Sugrue MF.
    Prog Retin Eye Res; 2000 Jan; 19(1):87-112. PubMed ID: 10614682
    [Abstract] [Full Text] [Related]

  • 5. Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes.
    Ingram CJ, Brubaker RF.
    Am J Ophthalmol; 1999 Sep; 128(3):292-6. PubMed ID: 10511022
    [Abstract] [Full Text] [Related]

  • 6. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
    Jansook P, Stefánsson E, Thorsteinsdóttir M, Sigurdsson BB, Kristjánsdóttir SS, Bas JF, Sigurdsson HH, Loftsson T.
    Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867
    [Abstract] [Full Text] [Related]

  • 7. Increased optic nerve head blood flow after 1 week of twice daily topical brinzolamide treatment in Dutch-belted rabbits.
    Barnes GE, Li B, Dean T, Chandler ML.
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S131-40. PubMed ID: 10665515
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive Ocular and Systemic Pharmacokinetics of Brinzolamide in Rabbits After Intracameral, Topical, and Intravenous Administration.
    Naageshwaran V, Ranta VP, Gum G, Bhoopathy S, Urtti A, Del Amo EM.
    J Pharm Sci; 2021 Jan; 110(1):529-535. PubMed ID: 33035542
    [Abstract] [Full Text] [Related]

  • 9. Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Brinzolamide Comfort Study Group.
    Silver LH.
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S141-5. PubMed ID: 10665516
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Silver LH.
    Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Sall K.
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S155-62. PubMed ID: 10665518
    [Abstract] [Full Text] [Related]

  • 12. Effects of dorzolamide hydrochloride on ocular tissues.
    Inoue J, Oka M, Aoyama Y, Kobayashi S, Ueno S, Hada N, Takeda T, Takehana M.
    J Ocul Pharmacol Ther; 2004 Feb; 20(1):1-13. PubMed ID: 15006154
    [Abstract] [Full Text] [Related]

  • 13. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C, Melilli B, Piazza C, Zurria M, Drago F.
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [Abstract] [Full Text] [Related]

  • 14. A one-week comfort study of BID-dosed brinzolamide 1%/timolol 0.5% ophthalmic suspension fixed combination compared to BID-dosed dorzolamide 2%/timolol 0.5% ophthalmic solution in patients with open-angle glaucoma or ocular hypertension.
    Vold SD, Evans RM, Stewart RH, Walters T, Mallick S.
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):601-5. PubMed ID: 19049301
    [Abstract] [Full Text] [Related]

  • 15. Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.
    Cvetkovic RS, Perry CM.
    Drugs Aging; 2003 Dec; 20(12):919-47. PubMed ID: 14565787
    [Abstract] [Full Text] [Related]

  • 16. Topical drug delivery to the eye: dorzolamide.
    Loftsson T, Jansook P, Stefánsson E.
    Acta Ophthalmol; 2012 Nov; 90(7):603-8. PubMed ID: 22269010
    [Abstract] [Full Text] [Related]

  • 17. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE, Friren B, International Brinzolamide Adjunctive Study Group.
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [Abstract] [Full Text] [Related]

  • 18. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
    Gugleta K.
    Curr Med Res Opin; 2010 Jun; 26(6):1255-67. PubMed ID: 20350146
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and evaluation of NO-donor containing carbonic anhydrase inhibitors to lower intraocular pressure.
    Huang Q, Rui EY, Cobbs M, Dinh DM, Gukasyan HJ, Lafontaine JA, Mehta S, Patterson BD, Rewolinski DA, Richardson PF, Edwards MP.
    J Med Chem; 2015 Mar 26; 58(6):2821-33. PubMed ID: 25728019
    [Abstract] [Full Text] [Related]

  • 20. Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration.
    Sigurdsson HH, Stefánsson E, Gudmundsdóttir E, Eysteinsson T, Thorsteinsdóttir M, Loftsson T.
    J Control Release; 2005 Jan 20; 102(1):255-62. PubMed ID: 15653150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.